Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62013TN0583

    Case T-583/13: Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission

    IO C 377, 21.12.2013, p. 19–19 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    21.12.2013   

    EN

    Official Journal of the European Union

    C 377/19

    Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission

    (Case T-583/13)

    2013/C 377/43

    Language of the case: English

    Parties

    Applicant: Shire Pharmaceutical Contracts (Hampshire, United Kingdom) (represented by: K. Bacon, Barrister, M. Utges Manley and M. Vickers, Solicitors)

    Defendant: European Commission

    Form of order sought

    The applicant claims that the Court should:

    —

    Annul the decision contained in the letter of the European Commission dated 2 September 2013, confirmed by the letter dated 18 October 2013, refusing eligibility for a reward for a voluntary pediatric investigation plan under Article 37 of Regulation (EC) No 1901/2006 (1); and

    —

    Order the defendant to bear the applicant’s costs.

    Pleas in law and main arguments

    In support of the action, the applicant relies on two pleas in law.

    1.

    First plea in law, alleging that the contested decision is vitiated by fundamental errors in law in the interpretation of Regulation (EC) No 1901/2006.

    2.

    Second plea in law, alleging a breach of the principle of legal certainty.

    (1)  Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ 2006 L 378, p. 1)

    Top